1. Generics Bulletin
  3. >>Deals

Exclusive: FTC Expected To Make Mylan-Upjohn Announcement Today

FTC Approval A Major Hurdle To Deal Completion

 
• By Dean Rudge

Almost 500 days after the transaction was first announced, Viatris, the proposed combination of Mylan and Pfizer’s Upjohn, is set to receive word from the US Federal Trade Commission, representing the last major obstacle to getting the deal over the line.

WASHINGTON, DC - SEPTEMBER 28, 2013: Federal Trade Commission Building in Washington, DC.
The FTC has revealed exclusively to Generics Bulletin that it will make an announcement on Viatris today. • Source: Shutterstock

The US Federal Trade Commission has told Generics Bulletin that it expects to make an announcement later today for Mylan’s pending combination with Pfizer’s Upjohn off-patent and mature brands unit, which has been in the works for 15 months amid the coronavirus pandemic.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business